1/133
slide 57
How many schedules of controlled substances are there under Massachusetts Law?
6
What is the purpose of MGL Chapter 94C, Section 2(a)?
It establishes a system of controlled substance schedules to regulate the manufacture, distribution, dispensing, and possession of controlled substances by persons authorized under the chapter.
Who is responsible for establishing Massachusetts' controlled substance schedules under Section 2(a)?
The Commissioner, through regulations.
How many controlled substance schedules must the Commissioner establish under MGL Chapter 94C, Section 2(a)?
Six schedules: the five schedules established under federal law, plus a sixth schedule for certain prescription drugs.
What federal law provides the basis for Massachusetts' first five controlled substance schedules?
The Comprehensive Drug Abuse Prevention and Control Act of 1970, including any amendments.
What must Massachusetts' first five controlled substance schedules incorporate?
They must incorporate the five federal controlled substance schedules established under the Comprehensive Drug Abuse Prevention and Control Act of 1970, including amendments.
What does Massachusetts' sixth controlled substance schedule include under Section 2(a)?
It includes all prescription drugs that are not included in the first five schedules.
What is the key difference between Massachusetts' first five schedules and its sixth schedule?
The first five schedules incorporate the federal controlled substance schedules. The sixth schedule includes prescription drugs that are not included in Schedules I–V.
What four activities involving controlled substances are specifically listed in Section 2(a)?
Manufacture
Distribution
Dispensing
Possession
What is the potential for abuse of Schedule I substances?
They have a high potential for abuse.
Do Schedule I substances have a currently accepted medical use in the United States?
No. They have no currently accepted medical use in treatment in the United States.
What does MGL Chapter 94C, Section 3 say about the safety of Schedule I substances?
There is a lack of accepted safety for use under medical supervision.
What are the three main characteristics of Schedule I substances?
High potential for abuse.
No currently accepted medical use in the United States.
Lack of accepted safety for use under medical supervision.
What is the potential for abuse of Schedule II substances?
They have a high potential for abuse.
Do Schedule II substances have an accepted medical use in the United States?
Yes. They have a currently accepted medical use, sometimes with severe restrictions.
What type of dependence may result from Schedule II substance abuse?
Abuse may lead to severe physical or psychological dependence.
What are the three main characteristics of Schedule II substances?
High potential for abuse.
Accepted medical use, sometimes with severe restrictions.
Risk of severe physical or psychological dependence.
How does the abuse potential of Schedule III substances compare with Schedules I and II?
Schedule III substances have a lower potential for abuse than substances in Schedules I and II.
Do Schedule III substances have an accepted medical use in the United States?
Yes. They have a currently accepted medical use in treatment in the United States.
What type of dependence may result from Schedule III substance abuse?
Abuse may lead to moderate or low physical dependence or high psychological dependence.
What are the three main characteristics of Schedule III substances?
Lower abuse potential than Schedules I and II.
Accepted medical use.
Risk of moderate or low physical dependence or high psychological dependence.
How does the abuse potential of Schedule IV substances compare with Schedule III?
Schedule IV substances have a low potential for abuse relative to Schedule III.
Do Schedule IV substances have an accepted medical use in the United States?
Yes. They have a currently accepted medical use.
What type of dependence may result from Schedule IV substance abuse?
Abuse may lead to limited physical or psychological dependence relative to Schedule III.
What are the three main characteristics of Schedule IV substances?
Low abuse potential compared with Schedule III.
Accepted medical use.
Risk of limited physical or psychological dependence compared with Schedule III.
How does the abuse potential of Schedule V substances compare with Schedule IV?
Schedule V substances have a low potential for abuse relative to Schedule IV.
Do Schedule V substances have an accepted medical use in the United States?
Yes. They have a currently accepted medical use.
What type of dependence may result from Schedule V substance abuse?
Abuse may lead to limited physical or psychological dependence relative to Schedule IV.
What are the three main characteristics of Schedule V substances?
Low abuse potential compared with Schedule IV.
Accepted medical use.
Risk of limited physical or psychological dependence compared with Schedule IV.
What type of substances are included in Schedule VI under Massachusetts law?
Schedule VI includes prescription drugs that are not included in Schedules I through V.
What two conditions must a drug meet to be included in Schedule VI?
It must be a prescription drug.
It must not be included in Schedules I through V.
How does Schedule VI differ from Schedules I–V under MGL Chapter 94C, Section 3?
Schedules I–V classify substances according to their abuse potential, medical use, and dependence risks. Schedule VI includes prescription drugs that are not classified in the first five schedules.
How does abuse potential generally change from Schedule I through Schedule V?
Abuse potential generally decreases as you move from Schedule I toward Schedule V. Schedule I has no currently accepted medical use, while Schedules II–V have accepted medical uses.
Which schedules describe substances with no currently accepted medical use versus accepted medical use?
Schedule I: No currently accepted medical use.
Schedules II–V: Currently accepted medical use, with Schedule II potentially subject to severe restrictions.
Schedule VI: Prescription drugs not included in Schedules I–V.
What is the general rule for dispensing Schedule II controlled substances under MGL Chapter 94C, Section 17(a)?
A Schedule II controlled substance cannot be dispensed without an electronic prescription from a practitioner, except for applicable exceptions.
What is the general rule for dispensing Schedule III, IV, V, and VI controlled substances under Section 17(c)?
These controlled substances cannot be dispensed without an electronic prescription from a practitioner, except for applicable exceptions.
Which controlled substance schedules are covered by the electronic prescription requirement in MGL Chapter 94C, Section 17?
Schedules II, III, IV, V, and VI.
Can a controlled substance be dispensed without an electronic prescription during an emergency?
Yes. In emergency situations as defined by the Commissioner, a Schedule II, III, IV, V, or VI substance may be dispensed using a written or oral prescription in accordance with Section 20 and related regulations.
Which schedules qualify for the emergency prescription exception under Section 17(b)?
Schedules II, III, IV, V, and VI.
What types of prescriptions may be used under the emergency exception in Section 17(b)?
A written prescription or an oral prescription, in accordance with Section 20 and related regulations.
Who defines the emergency situations that qualify for the exception under Section 17(b)?
The Commissioner, through regulations.
What is the difference between the general rule and the emergency exception under MGL Chapter 94C, Section 17?
The general rule requires an electronic prescription for controlled substances in Schedules II–VI. In qualifying emergencies, a written or oral prescription may be used instead, following Section 20 and related regulations.
Does the emergency exception apply only to Schedule II controlled substances?
No. It applies to controlled substances in Schedules II, III, IV, V, and VI.
Who may issue a prescription for a controlled substance under MGL Chapter 94C, Section 18(a)?
Only a practitioner who meets both requirements:
Is authorized to prescribe controlled substances.
Is registered under MGL Chapter 94C.
What two requirements must a practitioner meet to prescribe a controlled substance under Section 18(a)?
The practitioner must be authorized to prescribe controlled substances and registered under the chapter.
Can an employee or agent independently prescribe a controlled substance on behalf of a practitioner?
No. The prescription must be issued by a practitioner who is authorized and registered. An employee or agent may communicate an oral prescription only when expressly authorized by the practitioner.
Who may communicate an oral controlled substance prescription to a pharmacist under Section 18(b)?
An expressly authorized employee or agent of the practitioner may communicate the practitioner's oral prescription to the pharmacist.
Does an employee or agent need express authorization to communicate an oral prescription under Section 18(b)?
Yes. The employee or agent must be expressly authorized by the practitioner.
What is the difference between issuing and communicating a controlled substance prescription under Section 18?
Issuing: The authorized and registered practitioner creates the prescription.
Communicating: An expressly authorized employee or agent may relay the practitioner's oral prescription to the pharmacist.
Who may issue a Schedule III–VI controlled substance prescription that can be filled in Massachusetts under Section 18(c)?
An out-of-state practitioner who is:
Licensed and authorized to prescribe.
Registered in the state where they reside, if required.
Registered under federal law to write prescriptions.
What is the pharmacist's responsibility when filling an out-of-state Schedule III–VI prescription?
The pharmacist must use professional standards and personal judgment to determine whether the prescription is authentic and valid.
How must a pharmacist verify an out-of-state prescription for a Schedule III–V controlled substance under Section 18(c)?
The pharmacist must verify it by telephone or another means.
Can a pharmacist fill an out-of-state Schedule III–V prescription if its verification cannot be obtained?
No. The pharmacist must not fill it if verification cannot be obtained.
Can a pharmacist be held liable for refusing to fill an out-of-state prescription that cannot be verified?
The pharmacist is not held liable for refusing to fill it, provided they made and documented good-faith efforts to determine its authenticity and validity.
How old can an out-of-state Schedule III–VI prescription be and still qualify under Section 18(c)?
It must have been issued within the preceding 30 days.
Does Section 18(c) allow an out-of-state practitioner to practice in Massachusetts or dispense controlled substances there?
No. This provision only authorizes the filling of qualifying prescriptions. It does not authorize the practitioner to practice in Massachusetts or possess, administer, or dispense controlled substances under Section 9.
What must a pharmacist do when receiving an oral out-of-state prescription for a Schedule III–V substance?
The pharmacist must record that they requested the practitioner to deliver or mail a written prescription to the dispensing pharmacy within 7 days, or a shorter period if required by federal law.
Do the out-of-state prescription provisions in Section 18(c) authorize mail-order pharmacies?
No. The provision specifically states that it does not authorize mail-order pharmacies.
Can an out-of-state practitioner issue a prescription for a non-narcotic Schedule II substance that may be filled in Massachusetts?
Yes, if the practitioner is licensed and authorized to prescribe, registered in the state where they reside or practice if required, and registered under federal law to write prescriptions
How must a pharmacist verify an out-of-state prescription for a non-narcotic Schedule II substance?
The pharmacist must determine that it is authentic and valid using professional standards and personal judgment, and verify it by telephone or another means
How recently must an out-of-state non-narcotic Schedule II prescription have been issued to qualify under this provision?
Within the preceding 5 days.
Can a pharmacist fill an out-of-state non-narcotic Schedule II prescription if verification cannot be obtained?
No. The pharmacist must not fill it if verification cannot be obtained.
What must a pharmacist do with an out-of-state non-narcotic Schedule II prescription after filling it?
Within 30 days after filling it, the pharmacist must deliver a copy of the prescription to the Department.
What patient information must be excluded from the copy of an out-of-state non-narcotic Schedule II prescription sent to the Department?
The patient's name and address must be excluded. The copy is also subject to the applicable public-record and privacy restrictions described in the law.
Does the out-of-state non-narcotic Schedule II prescription provision authorize the practitioner to practice in Massachusetts or dispense controlled substances there?
No. It only authorizes the filling of qualifying prescriptions in Massachusetts.
Which out-of-state practitioners may issue prescriptions for narcotic Schedule II substances that can be filled in Massachusetts under this provision?
Practitioners licensed and authorized to prescribe who are registered in Maine or a state contiguous with Massachusetts, where they reside or practice, if registration is required, and who are registered under federal law to write prescriptions. The provision is subject to Section 18A.
How must a pharmacist verify an out-of-state narcotic Schedule II prescription?
The pharmacist must use professional standards and personal judgment to determine authenticity and validity, and verify the prescription by telephone or another means.
How recently must an out-of-state narcotic Schedule II prescription have been issued?
Within the preceding 5 days.
What must a pharmacist do after filling an eligible out-of-state narcotic Schedule II prescription?
Within 30 days after filling it, the pharmacist must deliver a copy of the prescription to the Department.
What patient information must be excluded from the copy of an out-of-state narcotic Schedule II prescription sent to the Department?
The patient's name and address must be excluded. The copy and its information are not public records under the provisions described in the law and are subject to applicable privacy restrictions.
Does the out-of-state narcotic Schedule II provision authorize the practitioner to practice in Massachusetts or possess, administer, or dispense controlled substances there?
No. It only authorizes the filling of qualifying prescriptions in Massachusetts.
Do the out-of-state narcotic Schedule II prescription rules authorize mail-order pharmacies?
No
Can a pharmacist dispense less than the full prescribed quantity of a Schedule II substance?
Yes. If the patient requests it, the pharmacist must dispense the prescribed substance in a quantity smaller than the amount written on the prescription.
Who may request the remaining portion of a partially filled Schedule II prescription?
The patient may request the remaining portion, subject to federal law.
Which pharmacy may dispense the remaining portion of a partially filled Schedule II prescription?
Only the same pharmacy that originally dispensed the smaller quantity may dispense the remainder.
What must the pharmacist or their designee document after an initial partial dispensing or dispensing the remaining portion?
They must make a notation in the patient's pharmacy record indicating:
That the prescription was partially filled.
The quantity dispensed.
Who must be able to access the record of a partially filled Schedule II prescription?
The prescribing practitioner must be able to access the record upon request.
When must the initial partial dispensing of a prescription covered by the specified subsections be completed?
Within 5 days after the prescription's issue date.
What is the deadline for dispensing the remaining portion of a partially filled Schedule II prescription under Section 18(d3/4) ?
the remaining portion must be dispensed no later than 30 days after the prescription's issue date.
What are the key requirements for patient-requested partial dispensing of a Schedule II prescription under Section 18?
The patient must request the smaller quantity.
The patient may request the remainder, subject to federal law.
Only the original dispensing pharmacy may dispense the remainder.
The pharmacist or designee must document the partial fill and quantity in the patient's record.
The record must be accessible to the prescriber upon request.
The initial partial dispensing must occur within 5 days, and the remainder must be dispensed within 30 days of the issue date under the specified provision.
Which practitioners must complete controlled-substance-related training as a prerequisite to obtaining or renewing their professional licenses under Section 18(e)?
Practitioners who prescribe controlled substances, except veterinarians.
What must the required training for practitioners cover regarding pain management?
It must cover effective pain management, including:
Appropriate available non-opioid alternatives.
The advantages and disadvantages of non-opioid alternatives, considering the patient's risk of substance misuse.
Options for referring or prescribing non-opioid alternatives based on clinical judgment and accepted guidelines, while considering the patient's preferences and consent.
What must the training for practitioners cover regarding opioids and addiction?
The risks of misuse and addiction associated with opioid medications.
Who develops the standards for appropriate practitioner training programs under Section 18(e)?
The boards of registration responsible for each professional license requiring the training, in consultation with the Department, relevant stakeholders, and experts in acute and chronic pain treatment and management.
What is the purpose of MGL Chapter 94C, Section 18A?
It establishes requirements for prescribing extended-release, long-acting opioids in a non-abuse-deterrent form for outpatient use, including patient evaluation and pain management agreements.
What must a practitioner do before prescribing an extended-release, long-acting opioid in a non-abuse-deterrent form for outpatient use for the first time?
The practitioner must:
Evaluate the patient's current condition, risk factors, history of substance abuse, if any, and current medications.
Inform the patient that, in the practitioner's medical opinion, the medication is an appropriate treatment based on the patient's medical needs.
What patient factors must a practitioner evaluate before first prescribing an extended-release, long-acting opioid in a non-abuse-deterrent form for outpatient use?
The practitioner must evaluate:
The patient's current condition.
Risk factors.
History of substance abuse, if any.
Current medications.
What must the practitioner document in the patient's medical record before first prescribing this type of opioid for outpatient use?
The practitioner must note that, in their medical opinion, the medication is an appropriate course of treatment based on the patient's medical needs.
What must the practitioner communicate to the patient before first prescribing an extended-release, long-acting opioid in a non-abuse-deterrent form for outpatient use?
The practitioner must inform the patient that the medication is considered an appropriate treatment based on the patient's medical needs, according to the practitioner's medical opinion.
When must a practitioner enter into a written pain management treatment agreement under Section 18A(b)?
When the practitioner recommends using an extended-release, long-acting opioid as part of long-term pain management.
Who must enter into the written pain management treatment agreement?
The practitioner registered under Section 7 and the patient.
What must a written pain management treatment agreement address?
It must appropriately address:
The benefits of the prescribed substance.
Risk factors for abuse or misuse of the prescribed substance.
Where must the written pain management treatment agreement be stored?
: It must be filed in the patient's medical record or included in the patient's electronic health record (EHR).
What is the difference between Section 18A(a) and Section 18A(b)?
Section 18A(a): Before the first outpatient prescription of an extended-release, long-acting opioid in a non-abuse-deterrent form, the practitioner must evaluate the patient and document the medical appropriateness of the treatment.
Section 18A(b): If the opioid is recommended for long-term pain management, the practitioner must enter into a written pain management treatment agreement with the patient.
What are the two main requirements to remember from MGL Chapter 94C, Section 18A?
First prescription: Evaluate the patient's condition, risks, substance abuse history, and medications; inform the patient and document the medical appropriateness of treatment.
Long-term pain management: Create a written agreement addressing benefits and risks of abuse or misuse, and keep it in the patient's medical record or EHR.
What is required when dispensing a Schedule II opioid in Massachusetts?
An opioid antagonist, such as naloxone, must be offered whenever a Schedule II opioid is dispensed.
What is an example of an opioid antagonist?
Naloxone
What information sheet must be distributed when dispensing a Schedule II or Schedule III prescription?
The Opioid Prescription Drug Fact Sheet must be distributed.
What has changed about the Opioid Prescription Drug Fact Sheet?
It has been updated to reflect changes in state law.
What is the key difference between the requirements for Schedule II opioids and Schedule II or III prescriptions?
Schedule II opioids: An opioid antagonist must be offered when dispensed.
Schedule II and III prescriptions: The Opioid Prescription Drug Fact Sheet must be distributed.